Results 71 to 80 of about 12,487 (241)

Self-Assembling Peptidomimetic Monolayer Nucleates Oriented CdS Nanocrystals

open access: yes, 2016
Self-Assembling Peptidomimetic Monolayer Nucleates Oriented CdS ...
Haimanot Bekele (3007545)   +2 more
core   +1 more source

De Novo Design of Multivalent α/β‐Peptides Mimicking Transcription Factors Targeting the CBP KIX Domain

open access: yesChemistry – A European Journal, EarlyView.
A modular, de novo α/β‐peptide design strategy allows fine‐tuning of ligand properties, resulting in multivalent ligands that simultaneously target separate binding sites on the protein surface. ABSTRACT Protein‐protein interactions that regulate gene expression in the nucleus are increasingly recognized as potential therapeutic targets but present ...
Márk V. Tresztián   +4 more
wiley   +1 more source

An Artificial Antiparallel β-Sheet Containing a New Peptidomimetic Template

open access: yes, 2016
An Artificial Antiparallel β-Sheet Containing a New Peptidomimetic ...
James S. Nowick (1272555)   +3 more
core   +1 more source

Extracellularly Activatable Conjugates of RGD Peptidomimetics and Cryptophycin for αVβ3‐Targeted Cancer Therapy

open access: yesChemistry – A European Journal, EarlyView.
Integrin αVβ3‐targeting small‐molecule drug conjugates (SMDCs) were synthesized by conjugating a cryptophycin payload through a neutrophil elastase‐cleavable NPV‐PABC linker. RGD peptidomimetic and linker epimers served as controls for targeting and enzymatic cleavage, and the resulting conjugates displayed subnanomolar cytotoxicity in vitro.
Dominic Seißenschmidt   +3 more
wiley   +1 more source

A non-hydrolysable peptidomimetic for mitochondrial targeting

open access: yes
Peptidomimetics, molecules that mimic the activity of natural peptides with improved stability or bioavailability, have emerged as interesting materials with applications in biomedicine.
Torralba-Maldonado, Daniel   +7 more
core   +1 more source

Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids

open access: yesMolecules, 2019
Lipid nanoparticles (LNP) are the most potent carriers for the delivery of nucleic acid-based therapeutics. The first FDA approved a short interfering RNA (siRNA) drug that uses a cationic LNP system for the delivery of siRNA against human transthyretin (
Ehexige Ehexige   +4 more
doaj   +1 more source

Synthesis of an IGD peptidomimetic with motogenic activity

open access: yes, 2005
Rational design and synthesis of an IGD peptidomimetic substrate with significant motogenic ...
Ellis, Ian R.; id_orcid   +7 more
core   +1 more source

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Malaria is a devastating disease caused by Plasmodium parasites. Plasmodium parasites express ten cathepsin D‐like aspartyl proteases, called plasmepsins (PMs). These PMs have diverse roles fulfill diverse functions throughout the parasite's lifecycle, though several exhibit functional redundancies. Among them, PMV, PMIV, and PMX are essential
Brad E. Sleebs
wiley   +1 more source

Promising Antibiofilm Activity of Peptidomimetics [PDF]

open access: yesFrontiers in Microbiology, 2018
Pathogenic biofilms are a global health care concern, as they can cause extensive antibiotic resistance, morbidity, mortality, and thereby substantial economic loss. Scientific efforts have been made over the past few decades, but so far there is no effective treatment targeting the bacteria in biofilms. Antimicrobial peptidomimetics have been proposed
Rafael Gomes Von Borowski   +4 more
openaire   +3 more sources

Novel Furanoid α-Substitued α-Amino Acid as a Potent Turn Mimic in Peptide Synthesis

open access: yesMolecules, 2006
A stereoselective approach has been developed to the new sugar amino acid and potential potent turn mimic 5-O-(tert-butyldimethylsilyl)-3-deoxy-1,2-O- isopropylidene-3-methoxycarbonylamino-α-D-xylofuranose 3-C-carboxylic acid (12), via the [3,3 ...
Jana Raschmanová   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy